Collaborative Testing Services (CTS) Proficiency Testing Supplies
Defense Health Agency · DEFENSE HEALTH AGENCY (DHA)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation HT942726CC0024 in this department, oldest first.
- Sep 9, 2026 · this noticeSpecial Notice
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
This notice announces the intent by the Defense Health Agency Contracting Activity (DHACA) Fort Detrick, Maryland, 21702, to award a sole source Firm-Fixed-Price (FFP) Contract to Collaborative Testing Services (CTS) under the statutory authority 12.102(a). The contract is for the purchase of Scheduled proficiency tests shipped at specified dates (vendor dependent) to include testing materials (bloodstains, dried body fluid stains, dried saliva samples) for the Armed Forces Medical Examiner System (AFMES), Armed Forces DNA Identification Laboratory (AFDIL). Collaborative Testing Services, LLC … (show all)
(CTS) is the only responsible source capable of providing the highly specialized proficiency testing supplies and services required to maintain the accreditation and operational integrity of the Armed Forces DNA Identification Laboratory (AFMES/AFDIL). While four proficiency testing providers are recognized by laboratory accrediting bodies�Collaborative Testing Services, Bode Cellmark Forensics, College of American Pathologists (CAP), and Serological Research Institute (SERI)�comprehensive market research and technical evaluation confirm that only CTS satisfies the agency�s minimum operational, throughput, and scientific requirements. The remaining three providers present critical technical deficiencies that make them unsuitable for AFDIL�s casework requirements: Bode Cellmark Forensics offers infrequent testing schedules that cannot support AFDIL�s staffing capacity or rolling test intervals; SERI imposes compressed completion windows that are incompatible with the extended processing times required by AFDIL�s advanced testing technologies; and CAP utilizes a manual, scan-based submission process that introduces an unacceptable risk of data transcription errors. In contrast, CTS uniquely provides the validated test substrates, electronic reporting infrastructure, and staggered distribution schedules necessary to efficiently test personnel on a continuous basis without disrupting critical forensic operations. Procuring these tests from any other source would jeopardize compliance with time-sensitive accreditation standards, compromise the validity of future casework, and introduce substantial risks to the laboratory's mission. CTS is the sole provider that meets all required sample matrices, capacity requirements, and distribution intervals. Delivery Date: 01 November 2026 The North American Industry Classification System (NAICS) for this requirement is 334516 and the size standard is 1,250 Employees. This is a notice of intent to issue a contract on a sole source basis. This notice of intent is NOT a request for quotations (RFQ). Any other firms desiring consideration must fully identify their interest in and capability to provide these services to the individual listed below. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. If no written responses are received by the expiration date listed in this notice, which reflects at least fifteen (15) days after the publication of this notice, the award will be issued as sole source. All questions and responses concerning this notice shall be emailed to Mr. Christopher L. Cook at christopher.l.cook68.civ@health.mil.
Who won similar work
15 award notices on SAM.gov in the last 24 months. Matched by: Same agency (Defense Health Agency), same product/service code (PSC) 6550.
Single-winner award sizes (15): middle half $272K to $1.9M, median $604K; range $111K to $4.7M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| SYSMEX AMERICA, INC | 2 | $2.8M | Oct 1, 2026 |
| WERFEN USA LLC | 2 | $580K | Aug 19, 2026 |
| BIOFIRE DEFENSE LLC | 1 | $4.7M | Apr 8, 2026 |
| ABBOTT LABORATORIES INC. · $ABT · $40.1B | 1 | $4.5M | Mar 10, 2026 |
| MAPP BIOPHARMACEUTICAL, INC. | 1 | $2.0M | Jun 4, 2025 |
| SAN DIEGO BLOOD BANK San Diego CA 92102 USA | 1 | $1.9M | Jun 22, 2025 |
| QUIDELORTHO SALES COMPANY · $QDEL · $3.0B | 1 | $837K | May 27, 2026 |
| LIFESTREAM BLOOD BANK San Bernardino CA 92408 USA | 1 | $650K | Feb 24, 2025 |
| SL MEDITECH CO. Seongnam-si GYEONGGI-DO 13103 KOR | 1 | $604K | Jun 11, 2026 |
| ARKRAY MARKETING, INC. | 1 | $332K | Nov 14, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $ABT reported $40.1B revenue in FY2025. The median single-winner award in these 15 past awards, $604K, is under 0.1% of that. 10-K
- $QDEL reported $3.0B revenue in FY2025. The median single-winner award in these 15 past awards, $604K, is under 0.1% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 1, 2026SYSMEX AMERICA, INC$2.7MFY26 Lab Consolidation for Coagulation CPRR Effort
- Aug 19, 2026WERFEN USA LLC$308KImmunohematology Reagents NMCSD
- Jun 11, 2026SL MEDITECH CO. Seongnam-si GYEONGGI-DO 13103 KOR$604KHematology and Coagulation Analyzers
- May 30, 2026ILLUMINA, INC.$273KIllumina Urinary Pathogen Identification (ID)/Antimicrobial Resistance (AMR) Enrichment Kit (UPIP), (1) Respiratory Pathogen ID/AMR Enrichment Kit Set A,
- May 27, 2026QUIDELORTHO SALES COMPANY$837KQuidel Ortho Reagents, Consumables and Maintenance
- Apr 8, 2026BIOFIRE DEFENSE LLC$4.7MBIOFIRE MOLECULAR ANALYZER AT NHCP
- Mar 10, 2026ABBOTT LABORATORIES INC.$4.5MChemistry Analyzer and Reagents Keesler AFB
- Jan 5, 2026WERFEN USA LLC$271KCoagulation Analyzers and Reagents Keesler AFB
- Dec 9, 2025SYSMEX AMERICA, INC$111KSole Source - Hematology Analyzer, JBPHH
- Nov 14, 2025ARKRAY MARKETING, INC.$332KArkray Urine Analyzers
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 2 of these past winners lobbied Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff since 2024 (13 filings)
- 0 of their lobbyists list a past Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff job
- $46K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Armed Services, Senate Committee on Appropriations, Senate Committee on Armed Services
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 32 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 2 of the past winners are listed companies
- 0 insider buys and 2 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.